Ghrelin

Ghrelin/obestatin prepropeptide
Available structures PDB Ortholog search: PDBe, RCSB List of PDB id codes 1P7X
Identifiers
Symbols	GHRL ; MTLRP
External IDs	OMIM: 605353 MGI: 1930008 HomoloGene: 9487 GeneCards: GHRL Gene
Gene ontology Molecular function • G-protein coupled receptor binding • protein binding • growth hormone-releasing hormone activity • protein tyrosine kinase activator activity • ghrelin receptor binding Cellular component • extracellular region • extracellular space • endoplasmic reticulum lumen • cytosol • axon • secretory granule lumen Biological process • activation of MAPK activity • gastric acid secretion • negative regulation of endothelial cell proliferation • glucose metabolic process • G-protein coupled receptor signaling pathway • positive regulation of cytosolic calcium ion concentration • actin polymerization or depolymerization • adult feeding behavior • response to hormone • hormone-mediated signaling pathway • dendrite development • negative regulation of angiogenesis • growth hormone secretion • positive regulation of insulin secretion • regulation of response to food • positive regulation of appetite • negative regulation of interleukin-1 beta production • negative regulation of locomotion • positive regulation of multicellular organism growth • regulation of cell proliferation • negative regulation of circadian sleep/wake cycle, REM sleep • negative regulation of tumor necrosis factor biosynthetic process • negative regulation of apoptotic process • cortisol secretion • response to estrogen • cellular protein metabolic process • negative regulation of interleukin-6 biosynthetic process • positive regulation of circadian sleep/wake cycle, non-REM sleep • negative regulation of insulin secretion • decidualization • negative regulation of inflammatory response • cartilage development • positive regulation of corticotropin secretion • positive regulation of cortisol secretion • positive regulation of synapse assembly • regulation of excitatory postsynaptic membrane potential • positive regulation of growth hormone secretion • positive regulation of growth hormone receptor signaling pathway • positive regulation of protein tyrosine kinase activity • negative regulation of energy homeostasis • positive regulation of energy homeostasis Sources: Amigo / QuickGO
Orthologs
Species	Human	Mouse
Entrez	51738	58991
Ensembl	ENSG00000157017	ENSMUSG00000064177
UniProt	Q9UBU3	Q9EQX0
RefSeq (mRNA)	NM_001134941	NM_001286404
RefSeq (protein)	NP_001128413	NP_001273333
Location (UCSC)	Chr 3: 10.29 – 10.29 Mb	Chr 6: 113.72 – 113.72 Mb
PubMed search	[1]	[2]

Ghrelin (pronounced GREL-in), the "hunger hormone", also known as lenomorelin (INN), is a peptide hormone produced by ghrelinergic cells in the gastrointestinal tract which functions as a neuropeptide in the central nervous system. Besides regulating appetite, ghrelin also plays a significant role in regulating the distribution and rate of use of energy.

When the stomach is empty, ghrelin is secreted. When the stomach is stretched, secretion stops. It acts on hypothalamic brain cells both to increase hunger, and to increase gastric acid secretion and gastrointestinal motility to prepare the body for food intake.

The receptor for ghrelin, the ghrelin/growth hormone secretagogue receptor (GHSR), is found on the same cells in the brain as the receptor for leptin, the satiety hormone that has opposite effects from ghrelin. Ghrelin also plays an important role in regulating reward perception in dopamine neurons that link the ventral tegmental area to the nucleus accumbens (a site that plays a role in processing sexual desire, reward, and reinforcement, and in developing addictions) through its colocalized receptors and interaction with dopamine and acetylcholine. Ghrelin is encoded by the GHRL gene and is presumably produced from the cleavage of the prepropeptide ghrelin/obestatin. Full-length preproghrelin is homologous to promotilin and both are members of the motilin family.

Unlike the case of many other endogenous peptides, ghrelin is able to cross the blood-brain-barrier, giving exogenously-administered ghrelin unique clinical potential.

History and name

Ghrelin was discovered after the ghrelin receptor (called growth hormone secretagogue type 1A receptor or GHSR) was discovered in 1996 and was reported in 1999. The hormone name is based on its role as a growth hormone-releasing peptide, with reference to the Proto-Indo-European root ghre-, meaning "to grow".

Gene, transcription products, and structure

Preproghrelin (green and blue) and ghrelin (green).

The GHRL gene produces mRNA which has four exons. Five products arise: the first is the 117-amino acid preproghrelin. (It is homologous to promotilin; both are members of the motilin family). It is cleaved to produce proghrelin which is cleaved to produce a 28-amino acid ghrelin (unacylated) and C-ghrelin(acylated). Obestatin is presumed to be cleaved from C-ghrelin.

Ghrelin only becomes active when caprylic (octanoic) acid is linked posttranslationally to serine at the 3-position by the enzyme ghrelin O-acyltransferase (GOAT). It is located on the cell membrane of ghrelin cells in the stomach and pancreas. The non-octanoylated form is desacyl ghrelin. It does not activate the GHSR receptor but does have other effects: cardiac, anti-ghrelin, appetite stimulation, and inhibition of hepatic glucose output Side-chains other than octanoyl have also been observed: these can also trigger the ghrelin receptor. In particular, decanoyl ghrelin has been found to constitute a significant portion of circulating ghrelin in mice, but as of 2011 its presence in humans has not been established.

Ghrelin cells

Alternate names

The ghrelin cell is also known as an A-like cell (pancreas), X-cell (for unknown function), X/A-like cell (rats), Epsilon cell (pancreas), P/D sub 1 cell (humans) and Gr cell (abbreviation for ghrelin cell).

Location

Ghrelin cells are found mainly in the stomach and duodenum, but also in the jejunum, lungs, pancreatic islets, gonads, adrenal cortex, placenta, and kidney. It has recently been shown that ghrelin is produced locally in the brain

Features

Ghrelin cells are found in oxyntic glands (20% of cells), pyloric glands, and small intestine. They are ovoid cells with granules. They have gastrin receptors. Some produce nesfatin-1. Ghrelin cells are not terminally differentiated in the pancreas: they are progenitor cells that can give rise to A-cells, PP cells and Beta-cells there.

Function and mechanism of action

Ghrelin is a participant in regulating the complex process of energy homeostasis which adjusts both energy input - by adjusting hunger signals - and energy output - by adjusting the proportion of energy going to ATP production, fat storage, glycogen storage, and short-term heat loss. The net result of these processes is reflected in body weight, and is under continuous monitoring and adjustment based on metabolic signals and needs. At any given moment in time, it may be in equilibrium or disequilibrium. Gastric-brain communication is an essential part of energy homeostasis, and several communication pathways are probable, including the gastric intracellular mTOR/S6K1 pathway mediating the interaction among ghrelin, nesfatin and endocannabinoid gastric systems, and both afferent and efferent vagal signals.

Ghrelin and synthetic ghrelin mimetics (growth hormone secretagogues) increase appetite and fat mass by triggering receptors in the arcuate nucleus that include the orexigenic neuropeptide Y (NPY) neurons. Ghrelin-responsiveness of these neurons is both leptin- and insulin-sensitive. Ghrelin reduces the mechanosensitivity of gastric vagal afferents, so they are less sensitive to gastric distension.

In addition to its function in energy homeostasis, ghrelin also activates the mesolimbic cholinergic–dopaminergic reward link, a circuit that communicates the hedonic and reinforcing aspects of natural rewards, such as food and addictive drugs such as ethanol. Ghrelin receptors are located on neurons in this circuit. Hypothalamic ghrelin signalling is required for reward from alcohol and palatable/rewarding foods.

Ghrelin also improves endothelial function and inhibits proatherogenic changes in cell cultures. It activates the endothelial isoform of nitric oxide synthase in a pathway that depends on various kinases including Akt.

Ghrelin has been linked to inducing appetite and feeding behaviors. Circulating ghrelin levels are the highest right before a meal and the lowest right after. Injections of ghrelin in both humans and rats have been shown to increase food intake in a dose-dependent manner. So the more ghrelin that is injected the more food that is consumed. However, ghrelin does not increase meal size, only meal number. Ghrelin injections also increase an animal's motivation to seek out food, behaviors including increased sniffing, foraging for food, and hoarding food. Body weight is regulated through energy balance, the amount of energy taken in versus the amount of energy expended over an extended period of time. Studies have shown that ghrelin levels are negatively correlated with weight. This data suggests that ghrelin functions as an adiposity signal, a messenger between the body's energy stores and the brain. When a person loses weight their ghrelin levels increase, which causes increased food consumption and weight gain. On the other hand, when a person gains weight, ghrelin levels drop, leading to a decrease in food consumption and weight loss. This suggests that ghrelin acts as a body weight regulator, continuously keeping one's body weight and energy stores in check.

Blood levels

Blood levels are in the pmol/l range. Both active and total ghrelin can be measured. Circulating ghrelin concentrations rise before eating and fall afterward, more strongly in response to protein and carbohydrate than to lipids.

Ghrelin receptor

The ghrelin receptor GHSR1a (a splice-variant of the growth hormone secretagogue receptor, with the GHSR1b splice being inactive) is involved in mediating a wide variety of biological effects of ghrelin, including: stimulation of growth hormone release, increase in hunger, modulation of glucose and lipid metabolism, regulation of gastrointestinal motility and secretion, protection of neuronal and cardiovascular cells, and regulation of immune function. They are present in high density in the hypothalamus and pituitary, on the vagus nerve (on both afferent cell bodies and afferent nerve endings) and throughout the gastrointestinal tract.

Locations of action

Gastrointestinal tract

Ghrelin promotes intestinal cell proliferation and inhibits apoptosis during inflammatory states and oxidative stress. It also suppresses pro-inflammatory mechanisms and augments anti-inflammatory mechanisms, thus creating a possibility of its therapeutic use in various gastrointestinal inflammatory conditions, including colitis, ischemia reperfusion injury, and sepsis. Animal models of colitis, ischemia reperfusion, and sepsis-related gut dysfunction have been shown to benefit from therapeutic doses of ghrelin. It has also been shown to have regenerative capacity and is beneficial in mucosal injury to the stomach.

Ghrelin promotes gastrointestinal and pancreatic malignancy.

Pancreas

Ghrelin acts on its receptor in the pancreas to inhibit glucose-stimulated insulin secretion.

Glucose metabolism

The entire ghrelin system (dAG, AG, GHSR and GOAT) has a gluco-regulatory action.

Nervous system

Learning and memory

The hippocampus plays a significant role in neurotrophy: the cognitive adaptation to changing environments and the process of learning and it is a potent stimulator of growth hormone. Animal models indicate that ghrelin may enter the hippocampus from the bloodstream, altering nerve-cell connections, and so altering learning and memory. It is suggested that learning may be best during the day and when the stomach is empty, since ghrelin levels are higher at these times. A similar effect on human memory performance is possible. In rodents, X/A-like cells produce ghrelin.

Depression

Ghrelin knock-out mice (who never express ghrelin) have increased anxiety in response to a variety of stressors, such as acute restraint stress and social stress in experimental settings. In normal mice, ghrelin can stimulate the hypothalamic-pituitary-adrenal axis, from the anterior pituitary.

Ghrelin has been shown to have implications for depression prevention. Antidepressant-like attributes were demonstrated when mice with high levels of ghrelin and mice with the ghrelin gene knocked out underwent social defeat stress and then were placed in the forced swim tank. Mice with elevated ghrelin swam more than ghrelin deficient mice. These ghrelin-deficient mice exhibited more social avoidance as well. These mice did not exhibit depression-like behaviors when injected with a commonly prescribed antidepressant, suggesting that ghrelin acts as a short-term natural adaptation against depression.

Sleep duration

Short sleep duration is associated with high levels of ghrelin and obesity. An inverse relationship between the hours of sleep and blood plasma concentrations of ghrelin exists; as the hours of sleep increase, ghrelin levels trend lower and obesity is less likely.

Stress-induced fear

Prior stress exposure heightens fear learning during Pavlovian fear conditioning. Stress-related increases in ghrelin circulation were shown to be necessary and sufficient for stress to increase fear learning. Ghrelin was found to be upregulated by stress even in the absence of adrenal hormones. Blocking the ghrelin receptor during stress abolished stress-related enhancement of fear memory without blunting other markers of stress. These results suggest that ghrelin is a novel branch of the stress response. Human studies are needed to translate the use of anti-ghrelin treatments to prevent stress-induced psychiatric disorders.

Substantia nigra function

Ghrelin, through its receptor increases the concentration of dopamine in the substantia nigra.

Reproductive system

Ghrelin has inhibitory effects on gonadotropin-releasing hormone (GnRH) secretion. It may cause decreased fertility.

Fetus and neonate

• Ghrelin is produced early by the fetal lung and promotes lung growth.
• Cord blood levels of active and total ghrelin show a correlation between ghrelin levels and birth weight.

Immune system

Ghrelin gene products have several actions on acute and chronic inflammation and autoimmunity, with promising therapeutic applications.

Anorexia and obesity

• Ghrelin levels in the plasma of obese individuals are lower than those in leaner individuals, suggesting that ghrelin does not contribute to obesity, except in the cases of Prader-Willi syndrome-induced obesity, where high ghrelin levels are correlated with increased food intake.
• Those with anorexia nervosa have high plasma levels of ghrelin compared to both the constitutionally thin and normal-weight controls.
• The level of ghrelin increases during the time of day from midnight to dawn in thinner people, which suggests there is a flaw in the circadian rhythm of obese individuals.
• Ghrelin levels reflect release in a circadian rhythm which can be interrupted by exposure to light at night.
• Short sleep duration may also lead to obesity, through an increase of appetite via hormonal changes.
• Lack of sleep increases ghrelin, and decreases leptin, both effects producing increased hunger and obesity.

• Ghrelin levels are high in patients with cancer-induced cachexia.

Disease management

Gastric bypass surgery

Gastric bypass surgery not only reduces the gut's capacity for food but also dramatically lowers ghrelin levels compared to both lean controls and those that lost weight through dieting alone. However, studies are conflicting as to whether or not ghrelin levels return to nearly normal with gastric bypass patients in the long term after weight loss has stabilized. Bariatric surgeries involving vertical sleeve gastrectomy reduce plasma ghrelin levels by about 60% in the long term.

Medical management of obesity

Ghrelin is not FDA approved for any indication.

In rodents and pigs, an anti-obesity vaccine has been developed: it blocks the ghrelin receptor.

Aging

Ghrelin plasma concentration increases with age and this may contribute to the tendency for weight gain as people age.

Future clinical uses

• Synthetic ghrelin administration for cachexia of any cause and for hemodialysis patients is being investigated.
• Ghrelin suppresses seizures in animal models and is being investigated.
• Ghrelin is a gastric pro-kinetic and may be useful in the treatment of gastroparesis.

Notes

• ^a Caution should be taken, it is not unanimous this sentence, e.g. "this finding appears to discount gastric distention as a mechanism for ghrelin reduction".